Funding pharma whistleblowers
Tuesday, January 4, 2011 - 12:01
in Mathematics & Economics
US whistleblower lawsuits filed against drug companies could provide attractive investment opportunities for hedge funds
US whistleblower lawsuits filed against drug companies could provide attractive investment opportunities for hedge funds